EDVA · Endovia Health Sciences, Inc. · Executive Compensation
$0.15
+0.01 (+7.41%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next 12 months.”View the 10-Q filed Aug 19, 2026
Market Cap
$865,690
Shares
6.41M
Volume · Oct 20
452.51K
Avg daily vol (3M)
4.68M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| William Devereux | Former CFO | $2,178,837 |
| William Meissner | Former President | $1,613,976 |
| Robert Nistico | Former Chief Executive Officer and Director | $1,610,477 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert Nistico | CEO | $734,619 |
| William Meissner | President and CMO | $581,519 |
| Julius Ivancsits | CFO | $460,780 |
| William Devereux | Former CFO | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Robert Nistico | CEO | $347,525 |
| William Meissner | President and CMO | $333,125 |
| Ronald Wall | CFO | $249,438 |
| Fatima Dhalla | Interim CFO | $55,950 |
| Julius Ivancsits | CFO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ronald Wall | CFO | $560,237 |
| Robert Nistico | CEO | $439,000 |
| William Meissner | President and CMO | $415,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Bondurant | Chief Operating Officer | Appointed | 2026-06-12 |
| William Meissner | President | Resigned | 2026-05-15 |
| Brady Cobb | Interim Chief Executive Officer | Appointed | 2026-05-15 |
| Francis Knuettel II | Board | Appointed | 2026-04-27 |
| Robert Nistico | member of the Board of Directors | Resigned | 2026-04-24 |
| Justin Yorke | member of the Board of Directors | Resigned | 2026-04-24 |
| Brady Cobb | director | Appointed | 2026-02-06 |
| Martin Scott | interim Chief Financial Officer (principal financial and accounting officer) | Appointed | 2025-12-17 |
| William Devereux | Chief Financial Officer | Resigned | 2025-11-14 |
| Robert Nistico | Chief Executive Officer | Resigned | 2025-11-06 |
| Thomas Fore | Director | Appointed | 2025-04-03 |
| William "Bill" Devereux | Chief Financial Officer | Appointed | 2025-04-03 |
| Dr. John Paglia | independent director | Resigned | 2025-02-12 |
| Julius Ivancsits | Chief Financial Officer | Resigned | 2025-02-12 |
| Julius Ivancsits | Chief Financial Officer | Appointed | 2024-04-26 |
| Stacy McLaughlin | Chief Financial Officer | Resigned | 2024-03-29 |
| Dr. John Paglia | Director | Appointed | 2024-03-01 |
| Fatima Dhalla | Interim Chief Financial Officer | Resigned | 2024-01-30 |
| Stacy McLaughlin | Chief Financial Officer | Appointed | 2024-01-30 |
| Candace Crawford | independent director | Resigned | 2023-12-26 |
| Peter J. McDonough | independent director | Resigned | 2023-12-26 |
| Bill Caple | director | Appointed | 2023-10-10 |
| Candace Crawford | director | Appointed | 2023-10-10 |
| Peter McDonough | director | Appointed | 2023-10-10 |
| Justin Yorke | director | Appointed | 2023-10-10 |
Leadership
- Brady Cobb CEO, Board Member
- Robert Nistico Chairman, Board Member
- Dean Huge CFO
- Fatima Dhalla CFO
- Julius Ivancsits CFO
- Martin Scott CFO
- Stacy McLaughlin CFO
- William "Bill" Devereux CFO
- Michael Bondurant COO
- Candace Crawford Board Member
- Dr. John Paglia Board Member
- Francis Knuettel II Board Member
- Justin Yorke Board Member
- Thomas Fore Board Member